Atlas Trials

Cerebral Lymphoma B Cell Refractory

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cerebral Lymphoma B Cell Refractory

RecordFirmDate
Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine. (NCT01848652)University Hospital, Brest2013-10-01

Track Cerebral Lymphoma B Cell Refractory automatically

Every clearance here is in the API, with alerts when new ones post.